ALKERMES | ALKS - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2025 0.01 0.49 Oct/28
FY2026Q2 Jun/2026 -0.02 0.52 Jul/28
FY2026Q1 Mar/2026 -0.40 -0.4 0.13 May/05
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28




Eps Cambiamento Data
AbbVie USD 3.65 1 2026-06
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
ALKERMES USD 0 0.4 2026-06
Amgen USD 6.29 1.14 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
J&J USD 2.9 0.2 2026-06
Malin Corporation EUR -0.06 0.1 2023-12
Merck USD -0.13 1.15 2026-06
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 2.85 0.91 2026-06
Otsuka Holdings JPY 222.76 36.45 2026-06
Ovoca Bio EUR 0 0.06 2025-12
Pfizer USD 0.77 0.02 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06